BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

848 related articles for article (PubMed ID: 19249262)

  • 1. Mesoporous calcium silicate for controlled release of bovine serum albumin protein.
    Xue W; Bandyopadhyay A; Bose S
    Acta Biomater; 2009 Jun; 5(5):1686-96. PubMed ID: 19249262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of luminescent and mesoporous Eu3+/Tb3+ doped calcium silicate microspheres as drug carriers via a template route.
    Kang X; Huang S; Yang P; Ma P; Yang D; Lin J
    Dalton Trans; 2011 Mar; 40(9):1873-9. PubMed ID: 21183970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A magnetic, luminescent and mesoporous core-shell structured composite material as drug carrier.
    Yang P; Quan Z; Hou Z; Li C; Kang X; Cheng Z; Lin J
    Biomaterials; 2009 Sep; 30(27):4786-95. PubMed ID: 19520428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, amino-functionalization of mesoporous silica and its adsorption of Cr(VI).
    Li J; Miao X; Hao Y; Zhao J; Sun X; Wang L
    J Colloid Interface Sci; 2008 Feb; 318(2):309-14. PubMed ID: 18036539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substitutions of strontium in mesoporous calcium silicate and their physicochemical and biological properties.
    Zhu Y; Zhu M; He X; Zhang J; Tao C
    Acta Biomater; 2013 May; 9(5):6723-31. PubMed ID: 23376133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstruction of calvarial defect of rabbits using porous calcium silicate bioactive ceramics.
    Xu S; Lin K; Wang Z; Chang J; Wang L; Lu J; Ning C
    Biomaterials; 2008 Jun; 29(17):2588-96. PubMed ID: 18378303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of bioactive mesoporous wollastonite - Polycaprolactone composite scaffold.
    Wei J; Chen F; Shin JW; Hong H; Dai C; Su J; Liu C
    Biomaterials; 2009 Feb; 30(6):1080-8. PubMed ID: 19019424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CaSiO₃ microstructure modulating the in vitro and in vivo bioactivity of poly(lactide-co-glycolide) microspheres.
    Wu C; Zhang Y; Fan W; Ke X; Hu X; Zhou Y; Xiao Y
    J Biomed Mater Res A; 2011 Jul; 98(1):122-31. PubMed ID: 21548064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro degradation, bioactivity, and cytocompatibility of calcium silicate, dimagnesium silicate, and tricalcium phosphate bioceramics.
    Ni S; Chang J
    J Biomater Appl; 2009 Aug; 24(2):139-58. PubMed ID: 18801892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of biocompatible, mesoporous Fe(3)O(4) nano/microspheres with large surface area for magnetic resonance imaging and therapeutic applications.
    Xuan S; Wang F; Lai JM; Sham KW; Wang YX; Lee SF; Yu JC; Cheng CH; Leung KC
    ACS Appl Mater Interfaces; 2011 Feb; 3(2):237-44. PubMed ID: 21229966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
    Yang P; Huang S; Kong D; Lin J; Fu H
    Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of titanium into calcium silicate improved their chemical stability and biological properties.
    Wu C; Ramaswamy Y; Soeparto A; Zreiqat H
    J Biomed Mater Res A; 2008 Aug; 86(2):402-10. PubMed ID: 17969034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyapatite particles as a controlled release carrier of protein.
    Matsumoto T; Okazaki M; Inoue M; Yamaguchi S; Kusunose T; Toyonaga T; Hamada Y; Takahashi J
    Biomaterials; 2004 Aug; 25(17):3807-12. PubMed ID: 15020156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan-coated mesoporous microspheres of calcium silicate hydrate: environmentally friendly synthesis and application as a highly efficient adsorbent for heavy metal ions.
    Zhao J; Zhu YJ; Wu J; Zheng JQ; Zhao XY; Lu BQ; Chen F
    J Colloid Interface Sci; 2014 Mar; 418():208-15. PubMed ID: 24461837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-CaSiO3/beta-Ca3(PO4)2 composite materials for hard tissue repair: in vitro studies.
    Ni S; Lin K; Chang J; Chou L
    J Biomed Mater Res A; 2008 Apr; 85(1):72-82. PubMed ID: 17688291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous silica/apatite nanocomposite: special synthesis route to control local drug delivery.
    Sousa A; Souza KC; Sousa EM
    Acta Biomater; 2008 May; 4(3):671-9. PubMed ID: 18206431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface microstructure and cell compatibility of calcium silicate and calcium phosphate composite coatings on Mg-Zn-Mn-Ca alloys for biomedical application.
    Du H; Wei Z; Wang H; Zhang E; Zuo L; Du L
    Colloids Surf B Biointerfaces; 2011 Mar; 83(1):96-102. PubMed ID: 21145712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mesoporous silica-based antibiotic releasing scaffold for bone repair.
    Shi X; Wang Y; Ren L; Zhao N; Gong Y; Wang DA
    Acta Biomater; 2009 Jun; 5(5):1697-707. PubMed ID: 19217361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescent mesoporous silica nanotubes incorporating CdS quantum dots for controlled release of ibuprofen.
    Yang YJ; Tao X; Hou Q; Chen JF
    Acta Biomater; 2009 Nov; 5(9):3488-96. PubMed ID: 19442764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The calcium silicate/alginate composite: preparation and evaluation of its behavior as bioactive injectable hydrogels.
    Han Y; Zeng Q; Li H; Chang J
    Acta Biomater; 2013 Nov; 9(11):9107-17. PubMed ID: 23796407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.